Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AGRX

Agile Therapeutics (AGRX) Stock Price, News & Analysis

Agile Therapeutics logo

About Agile Therapeutics Stock (NASDAQ:AGRX)

Advanced Chart

Key Stats

Today's Range
$1.51
$1.52
50-Day Range
$1.43
$1.51
52-Week Range
$0.20
$2.63
Volume
120,938 shs
Average Volume
352,864 shs
Market Capitalization
$10.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AGRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agile Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

AGRX Stock News Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
See More Headlines

AGRX Stock Analysis - Frequently Asked Questions

Agile Therapeutics, Inc. (NASDAQ:AGRX) released its quarterly earnings results on Tuesday, November, 2nd. The specialty pharmaceutical company reported ($7.20) earnings per share (EPS) for the quarter, topping the consensus estimate of ($7.60) by $0.40. The specialty pharmaceutical company earned $1.29 million during the quarter, compared to analysts' expectations of $1.49 million.
Read the conference call transcript
.

Agile Therapeutics shares reverse split on Wednesday, April 27th 2022.The 1-40 reverse split was announced on Wednesday, April 27th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, April 27th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Agile Therapeutics investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), CymaBay Therapeutics (CBAY), CrowdStrike (CRWD) and Arista Networks (ANET).

Company Calendar

Last Earnings
11/02/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AGRX
CIK
1261249
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.65)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.47 million
Net Margins
-36.24%
Pretax Margin
-36.24%
Return on Equity
N/A
Return on Assets
-147.37%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.56
Quick Ratio
0.38

Sales & Book Value

Annual Sales
$19.98 million
Price / Sales
0.52
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($5.51) per share
Price / Book
-0.27

Miscellaneous

Outstanding Shares
6,856,000
Free Float
6,822,000
Market Cap
$10.35 million
Optionable
Not Optionable
Beta
1.58

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:AGRX) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners